Chi Chen is a Senior Director and the CDx Head at Bayer, specializing in Companion Diagnostics, Precision Medicine, and Assay Development. They previously served as Director of Oncology Precision Medicine at Novartis Oncology from 2017 to 2021, and held various positions including Senior Scientist and Associate Director, CDx Assay Development. Chi obtained a PhD from Northwestern University in 2006 and a BS from Fudan University in 2000. Currently, they lead Global Diagnostics and Biomarker Operations in Oncology at Bayer Pharmaceuticals.
This person is not in the org chart
This person is not in any teams
This person is not in any offices